Targeting Insulin-Like Growth Factor-I and Insulin-Like Growth Factor–Binding Protein-3 Signaling Pathways. A Novel Therapeutic Approach for Asthma
出版年份 2013 全文链接
标题
Targeting Insulin-Like Growth Factor-I and Insulin-Like Growth Factor–Binding Protein-3 Signaling Pathways. A Novel Therapeutic Approach for Asthma
作者
关键词
-
出版物
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
Volume 50, Issue 4, Pages 667-677
出版商
American Thoracic Society
发表日期
2013-11-13
DOI
10.1165/rcmb.2013-0397tr
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tobacco specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone suppresses a newly identified anti-tumor IGFBP-3/IGFBP-3R system in lung cancer cells
- (2013) Aki Harada et al. LUNG CANCER
- IGFBP-3 Inhibits Cytokine-Induced Insulin Resistance and Early Manifestations of Atherosclerosis
- (2013) Lathika Mohanraj et al. PLoS One
- Recombinant IGFBP-3 inhibits allergic lung inflammation, VEGF production, and vascular leak in a mouse model of asthma
- (2012) S. R. Kim et al. ALLERGY
- Phase 1 study of ganitumab (AMG 479), a fully human monoclonal antibody against the insulin-like growth factor receptor type I (IGF1R), in Japanese patients with advanced solid tumors
- (2012) Haruyasu Murakami et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Insulin Growth Factor-Receptor (IGF-1R) Antibody Cixutumumab Combined with the mTOR Inhibitor Temsirolimus in Patients with Refractory Ewing's Sarcoma Family Tumors
- (2012) A. Naing et al. CLINICAL CANCER RESEARCH
- Inhibition of p38 MAPK Reduces Expression of Vascular Endothelial Growth Factor in Allergic Airway Disease
- (2012) So Ri Kim et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Insulin-like Growth Factor Receptor Inhibitors: Baby or the Bathwater?
- (2012) D. Yee JNCI-Journal of the National Cancer Institute
- A Phase I/II Study of Erlotinib in Combination with the Anti-Insulin-Like Growth Factor-1 Receptor Monoclonal Antibody IMC-A12 (Cixutumumab) in Patients with Advanced Non-small Cell Lung Cancer
- (2012) Andrew Weickhardt et al. Journal of Thoracic Oncology
- Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1/2 activation and Egr-1-mediated transcriptional events
- (2011) J.-H. Kim et al. BLOOD
- Insulin-like growth factor-binding protein-3 suppresses tumor growth via activation of caspase-dependent apoptosis and cross-talk with NF-κB signaling
- (2011) Jinfeng Han et al. CANCER LETTERS
- Dual IGF-I/II-Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth
- (2011) J. Gao et al. CANCER RESEARCH
- The role of the insulin-like growth factor signaling pathway in non-small cell lung cancer and other solid tumors
- (2011) Giorgio V. Scagliotti et al. CANCER TREATMENT REVIEWS
- Phase I Trial of Cixutumumab Combined with Temsirolimus in Patients with Advanced Cancer
- (2011) Aung Naing et al. CLINICAL CANCER RESEARCH
- Insulin-like Growth Factor-binding Protein-3 (IGFBP-3) Blocks the Effects of Asthma by Negatively Regulating NF-κB Signaling through IGFBP-3R-mediated Activation of Caspases
- (2011) Yong-Chul Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group
- (2011) Suman Malempati et al. JOURNAL OF CLINICAL ONCOLOGY
- Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: A review
- (2011) Emine Elif Ozkan MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Induction of insulin-like growth factor-I by interleukin-17F in bronchial epithelial cells
- (2010) M. Kawaguchi et al. CLINICAL AND EXPERIMENTAL ALLERGY
- HIF-1α inhibition ameliorates an allergic airway disease via VEGF suppression in bronchial epithelium
- (2010) So Ri Kim et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Identification of a Novel Cell Death Receptor Mediating IGFBP-3-induced Anti-tumor Effects in Breast and Prostate Cancer
- (2010) Angela R. Ingermann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Evidence that human bone cells in culture secrete insulin-like growth factor (IGF)-II and IGF binding protein-3 but not acid-labile subunit both under basal and regulated conditions
- (2010) Susumu Kanzaki et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Insulin-Like Growth Factor-I Regulation of Immune Function: A Potential Therapeutic Target in Autoimmune Diseases?
- (2010) T. J. Smith PHARMACOLOGICAL REVIEWS
- Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3
- (2009) Sophie S. Y. Chan et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Role of Insulin-like Growth Factor Binding Protein-3 in Allergic Airway Remodeling
- (2009) Kristen L. Veraldi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Unraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease
- (2009) Sherryline Jogie-Brahim et al. ENDOCRINE REVIEWS
- Phase I, Pharmacokinetic, and Pharmacodynamic Study of AMG 479, a Fully Human Monoclonal Antibody to Insulin-Like Growth Factor Receptor 1
- (2009) Anthony W. Tolcher et al. JOURNAL OF CLINICAL ONCOLOGY
- Peroxisome Proliferator-Activated Receptor Agonist Down-Regulates IL-17 Expression in a Murine Model of Allergic Airway Inflammation
- (2009) S. J. Park et al. JOURNAL OF IMMUNOLOGY
- Discovery of a 2,4-Disubstituted Pyrrolo[1,2-f][1,2,4]triazine Inhibitor (BMS-754807) of Insulin-like Growth Factor Receptor (IGF-1R) Kinase in Clinical Development
- (2009) Mark D. Wittman et al. JOURNAL OF MEDICINAL CHEMISTRY
- BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR
- (2009) J. M. Carboni et al. MOLECULAR CANCER THERAPEUTICS
- Mast Cells Can Mediate Vascular Permeability through Regulation of the PI3K–HIF-1α–VEGF Axis
- (2008) Kyung Sun Lee et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Clinical Significance of Plasma and Serum Vascular Endothelial Growth Factor in Asthma
- (2008) Ka Young Lee et al. JOURNAL OF ASTHMA
- IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis
- (2008) Weidong Zhu et al. NATURE
- New drugs targeting Th2 lymphocytes in asthma
- (2008) Gaetano Caramori et al. Journal of Occupational Medicine and Toxicology
- Inhibition of VEGF blocks TGF- 1 production through a PI3K/Akt signalling pathway
- (2007) K. S. Lee et al. EUROPEAN RESPIRATORY JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started